The behavioral phenotype of children and adolescents with attenuated non-ketotic hyperglycinemia, intermediate to good subtype

Orphanet J Rare Dis. 2024 Apr 8;19(1):150. doi: 10.1186/s13023-024-03172-3.

Abstract

Aim: We aim to describe the behavioral phenotype of children and adolescents with the good to intermediate attenuated form of non-ketotic hyperglycinemia (NKH) and to explore associations between the behavioral phenotype and age, sex, plasma glycine levels and drug treatment.

Method: Parents of children with attenuated NKH completed questionnaires assessing maladaptive behavior, adaptive behavior, social communication, speech/language development and motor development in addition to demographic and medical questions.

Results and interpretation: Twelve children, age 6 to 21y, functioned at mild to severe intellectual disability levels. Their speech/language development was in line with their developmental quotient. Relative to their intellectual functioning, their motor development and communication were weaker in comparison to their general development. Their adaptive behavior, however, appeared a relative strength. There was no evidence for autism spectrum disorder occurring more frequently than expected, rather social skills, except for communication, were rated as a relative strength. Maladaptive behaviors with ADHD-like characteristics were present in more than two thirds of children. Maladaptive behaviors were significantly related to female sex and to taking dextromethorphan, but no significant relation between plasma glycine levels and behavior was found. Future studies will need to evaluate causality in the observed relation between dextromethorphan use and maladaptive behaviors. Clinicians should reconsider the benefit of dextromethorphan when presented with disruptive behaviors in children with attenuated NKH.

Keywords: Behavior; Developmental delay; Dextromethorphan; Disruptive; Hyperactivity; Non-ketotic hyperglycinemia.

MeSH terms

  • Adolescent
  • Adult
  • Autism Spectrum Disorder* / drug therapy
  • Child
  • Dextromethorphan / therapeutic use
  • Female
  • Glycine / genetics
  • Glycine / therapeutic use
  • Humans
  • Hyperglycinemia, Nonketotic* / drug therapy
  • Hyperglycinemia, Nonketotic* / genetics
  • Phenotype
  • Young Adult

Substances

  • Dextromethorphan
  • Glycine